These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 16256784

  • 1. Attempted control of hyperglycemia during cardiopulmonary bypass fails to improve neurologic or neurobehavioral outcomes in patients without diabetes mellitus undergoing coronary artery bypass grafting.
    Butterworth J, Wagenknecht LE, Legault C, Zaccaro DJ, Kon ND, Hammon JW, Rogers AT, Troost BT, Stump DA, Furberg CD, Coker LH.
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1319. PubMed ID: 16256784
    [Abstract] [Full Text] [Related]

  • 2. Cardiopulmonary bypass increases postoperative glycemia and insulin consumption after coronary surgery.
    Knapik P, Nadziakiewicz P, Urbanska E, Saucha W, Herdynska M, Zembala M.
    Ann Thorac Surg; 2009 Jun; 87(6):1859-65. PubMed ID: 19463610
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.
    Carrier M, Ménasché P, Levy JH, Newman MF, Taylor KM, Haverich A, Chen JC, Shernan SK, Van de Werf F, van der Laan M, Todaro TG, Adams PX, Verrier ED.
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):352-6. PubMed ID: 16434264
    [Abstract] [Full Text] [Related]

  • 4. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial.
    Quinn DW, Pagano D, Bonser RS, Rooney SJ, Graham TR, Wilson IC, Keogh BE, Townend JN, Lewis ME, Nightingale P, Study Investigators.
    J Thorac Cardiovasc Surg; 2006 Jan; 131(1):34-42. PubMed ID: 16399292
    [Abstract] [Full Text] [Related]

  • 5. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
    El-Hamamsy I, Stevens LM, Carrier M, Pellerin M, Bouchard D, Demers P, Cartier R, Page P, Perrault LP.
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):7-12. PubMed ID: 17198774
    [Abstract] [Full Text] [Related]

  • 6. Increased risk associated with combined carotid endarterectomy and coronary artery bypass graft surgery: a propensity-matched comparison with isolated coronary artery bypass graft surgery.
    Cywinski JB, Koch CG, Krajewski LP, Smedira N, Li L, Starr NJ.
    J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):796-802. PubMed ID: 17138083
    [Abstract] [Full Text] [Related]

  • 7. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.
    Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A.
    J Thorac Cardiovasc Surg; 2003 May; 125(5):1007-21. PubMed ID: 12771873
    [Abstract] [Full Text] [Related]

  • 8. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial.
    Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G.
    J Neurosurg Anesthesiol; 2007 Jul; 19(3):156-60. PubMed ID: 17592345
    [Abstract] [Full Text] [Related]

  • 9. Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery.
    Jones KW, Cain AS, Mitchell JH, Millar RC, Rimmasch HL, French TK, Abbate SL, Roberts CA, Stevenson SR, Marshall D, Lappé DL.
    J Diabetes Complications; 2008 Jul; 22(6):365-70. PubMed ID: 18413193
    [Abstract] [Full Text] [Related]

  • 10. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.
    Shernan SK, Fitch JC, Nussmeier NA, Chen JC, Rollins SA, Mojcik CF, Malloy KJ, Todaro TG, Filloon T, Boyce SW, Gangahar DM, Goldberg M, Saidman LJ, Mangano DT, Pexelizumab Study Investigators.
    Ann Thorac Surg; 2004 Mar; 77(3):942-9; discussion 949-50. PubMed ID: 14992903
    [Abstract] [Full Text] [Related]

  • 11. Effects of cardiopulmonary bypass on glucose homeostasis after coronary artery bypass surgery.
    Anderson RE, Brismar K, Barr G, Ivert T.
    Eur J Cardiothorac Surg; 2005 Sep; 28(3):425-30. PubMed ID: 16054822
    [Abstract] [Full Text] [Related]

  • 12. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial.
    Kaya K, Oğuz M, Akar AR, Durdu S, Aslan A, Erturk S, Taşöz R, Ozyurda U.
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):290-7. PubMed ID: 17174559
    [Abstract] [Full Text] [Related]

  • 13. Centrifugal versus roller head pumps for cardiopulmonary bypass: effect on early neuropsychologic outcomes after coronary artery surgery.
    Scott DA, Silbert BS, Doyle TJ, Blyth C, Borton MC, O'brien JL, de L Horne DJ.
    J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):715-22. PubMed ID: 12486652
    [Abstract] [Full Text] [Related]

  • 14. Protective effect of ambroxol on pulmonary function after cardiopulmonary bypass.
    Ulas MM, Hizarci M, Kunt A, Ergun K, Kocabeyoglu SS, Korkmaz K, Lafci G, Gedik S, Cagli K.
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):518-23. PubMed ID: 19034033
    [Abstract] [Full Text] [Related]

  • 15. Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630].
    Hoedemaekers CW, Pickkers P, Netea MG, van Deuren M, Van der Hoeven JG.
    Crit Care; 2005 Dec; 9(6):R790-7. PubMed ID: 16356228
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Coronary artery bypass grafting with single cross-clamp results in fewer persistent neuropsychological deficits than multiple clamp or off-pump coronary artery bypass grafting.
    Hammon JW, Stump DA, Butterworth JF, Moody DM, Rorie K, Deal DD, Kincaid EH, Oaks TE, Kon ND.
    Ann Thorac Surg; 2007 Oct; 84(4):1174-8; discussion 1178-9. PubMed ID: 17888966
    [Abstract] [Full Text] [Related]

  • 19. Improvement of outcomes after coronary artery bypass II: a randomized trial comparing intraoperative high versus customized mean arterial pressure.
    Charlson ME, Peterson JC, Krieger KH, Hartman GS, Hollenberg JP, Briggs WM, Segal AZ, Parikh M, Thomas SJ, Donahue RG, Purcell MH, Pirraglia PA, Isom OW.
    J Card Surg; 2007 Oct; 22(6):465-72. PubMed ID: 18039205
    [Abstract] [Full Text] [Related]

  • 20. Is the use of cardiopulmonary bypass for isolated coronary artery bypass an independent predictor of mortality and morbidity in patients with severe left ventricular dysfunction?
    Qiu ZB, Chen X, Xu M, Shi KH, Jiang YS, Xiao LQ.
    Chin Med J (Engl); 2008 Dec 05; 121(23):2397-402. PubMed ID: 19102956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.